Related Experiment Video
Updated: Jun 19, 2026
14:23
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing
Tessa Dieltjens1, Nathalie Loots, Katleen Vereecken
1Department of Microbiology, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium. tdieltjens@itg.be
AIDS Research and Human Retroviruses
|November 6, 2009
Summary
This study tracks HIV-1 subtype A evolution in a donor with persistent cross-neutralizing antibodies. Virus Env changes, particularly in V1-V5 loops, may explain antibody escape while conserving key epitopes.
Area of Science:
- Virology
- Immunology
- HIV Research
Background:
- Understanding antibody escape mechanisms is crucial for effective HIV vaccine development.
- Long-term HIV infection studies can reveal viral adaptations and host immune responses.
- Cross-neutralizing antibodies (bNAbs) offer insights into potential vaccine targets.
Purpose of the Study:
- To investigate the Env antigenic variability in an HIV-1 subtype A-infected donor with sustained broad cross-neutralizing antibodies.
- To identify viral genetic changes associated with antibody escape and epitope conservation.
- To inform the design of immunogens for HIV vaccines.
Main Methods:
- Longitudinal analysis of viral Env gene sequences from an HIV-1 subtype A-infected donor.
- Characterization of V1-V5 loop sequence evolution and associated genetic changes.
- Correlation of viral evolution with the presence of broad cross-neutralizing antibodies.
Main Results:
- The donor's HIV-1 Env evolved with significant alterations in V1-V5 loops, V1 expansion, and V4-V5/C3 changes.
- Conserved V2 and V3 loop sequences were observed despite overall Env variability.
- Viral evolution involved sequence duplication and addition of cysteine and glycosylation sites in V1.
- These changes likely contributed to immune escape by altering epitope exposure.
Conclusions:
- HIV-1 Env evolution can involve complex changes to evade antibody responses.
- Conserved epitopes on the HIV Env may be critical for maintaining broad cross-neutralizing antibody activity.
- Understanding these dynamics is vital for designing effective HIV immunogens and vaccines.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...